About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Dysmenorrhea Treatment Market Size, Demand to 2031
Dysmenorrhea Treatment Market

Dysmenorrhea Treatment Market Size, Share & Trends Analysis Report By Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), By Type of Treatment (Pain Relievers, Hormonal Therapy, Surgery, Others), By End-User (Hospitals and Clinics, Research Centers, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI3595DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Dysmenorrhea Treatment Market Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Primary Dysmenorrhea
        1. By Value
      3. Secondary Dysmenorrhea
        1. By Value
    3. By Type of Treatment
      1. Introduction
        1. Type of Treatment By Value
      2. Pain Relievers
        1. By Value
      3. Hormonal Therapy
        1. By Value
      4. Surgery
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Research Centers
        1. By Value
      4. Others
        1. By Value
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Primary Dysmenorrhea
        1. By Value
      3. Secondary Dysmenorrhea
        1. By Value
    3. By Type of Treatment
      1. Introduction
        1. Type of Treatment By Value
      2. Pain Relievers
        1. By Value
      3. Hormonal Therapy
        1. By Value
      4. Surgery
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Research Centers
        1. By Value
      4. Others
        1. By Value
    5. U.S.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Primary Dysmenorrhea
          1. By Value
        3. Secondary Dysmenorrhea
          1. By Value
      2. By Type of Treatment
        1. Introduction
          1. Type of Treatment By Value
        2. Pain Relievers
          1. By Value
        3. Hormonal Therapy
          1. By Value
        4. Surgery
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Research Centers
          1. By Value
        4. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Primary Dysmenorrhea
        1. By Value
      3. Secondary Dysmenorrhea
        1. By Value
    3. By Type of Treatment
      1. Introduction
        1. Type of Treatment By Value
      2. Pain Relievers
        1. By Value
      3. Hormonal Therapy
        1. By Value
      4. Surgery
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Research Centers
        1. By Value
      4. Others
        1. By Value
    5. U.K.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Primary Dysmenorrhea
          1. By Value
        3. Secondary Dysmenorrhea
          1. By Value
      2. By Type of Treatment
        1. Introduction
          1. Type of Treatment By Value
        2. Pain Relievers
          1. By Value
        3. Hormonal Therapy
          1. By Value
        4. Surgery
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Research Centers
          1. By Value
        4. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Primary Dysmenorrhea
        1. By Value
      3. Secondary Dysmenorrhea
        1. By Value
    3. By Type of Treatment
      1. Introduction
        1. Type of Treatment By Value
      2. Pain Relievers
        1. By Value
      3. Hormonal Therapy
        1. By Value
      4. Surgery
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Research Centers
        1. By Value
      4. Others
        1. By Value
    5. China
      1. By Type
        1. Introduction
          1. Type By Value
        2. Primary Dysmenorrhea
          1. By Value
        3. Secondary Dysmenorrhea
          1. By Value
      2. By Type of Treatment
        1. Introduction
          1. Type of Treatment By Value
        2. Pain Relievers
          1. By Value
        3. Hormonal Therapy
          1. By Value
        4. Surgery
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Research Centers
          1. By Value
        4. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Primary Dysmenorrhea
        1. By Value
      3. Secondary Dysmenorrhea
        1. By Value
    3. By Type of Treatment
      1. Introduction
        1. Type of Treatment By Value
      2. Pain Relievers
        1. By Value
      3. Hormonal Therapy
        1. By Value
      4. Surgery
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Research Centers
        1. By Value
      4. Others
        1. By Value
    5. UAE
      1. By Type
        1. Introduction
          1. Type By Value
        2. Primary Dysmenorrhea
          1. By Value
        3. Secondary Dysmenorrhea
          1. By Value
      2. By Type of Treatment
        1. Introduction
          1. Type of Treatment By Value
        2. Pain Relievers
          1. By Value
        3. Hormonal Therapy
          1. By Value
        4. Surgery
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Research Centers
          1. By Value
        4. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Primary Dysmenorrhea
        1. By Value
      3. Secondary Dysmenorrhea
        1. By Value
    3. By Type of Treatment
      1. Introduction
        1. Type of Treatment By Value
      2. Pain Relievers
        1. By Value
      3. Hormonal Therapy
        1. By Value
      4. Surgery
        1. By Value
      5. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals and Clinics
        1. By Value
      3. Research Centers
        1. By Value
      4. Others
        1. By Value
    5. Brazil
      1. By Type
        1. Introduction
          1. Type By Value
        2. Primary Dysmenorrhea
          1. By Value
        3. Secondary Dysmenorrhea
          1. By Value
      2. By Type of Treatment
        1. Introduction
          1. Type of Treatment By Value
        2. Pain Relievers
          1. By Value
        3. Hormonal Therapy
          1. By Value
        4. Surgery
          1. By Value
        5. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals and Clinics
          1. By Value
        3. Research Centers
          1. By Value
        4. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Dysmenorrhea Treatment Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Johnson & Johnson Services Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Hoffmann-La Roche Ltd
    3. Bayer AG
    4. Novartis AG
    5. Pfizer Inc.
    6. Sanofi S.A.
    7. Reckitt Benckiser Group plc
    8. Viatris Inc
    9. Focus Consumer Healthcare
    10. GlaxoSmithKline PLC
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Insomnia Treatment Market Size The global insomnia treatment market size was valued at USD 3,858.86 million in 2024 and is expected to grow from USD 4,098.11 million in 2025 to USD 6,631.00 million by 2033, growing at a CAGR of 6.20%
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.